Open AccessRe: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia
Author(s) -
A.M. Shelley,
Lewis A. Opler,
Joseph Battaglia,
Jeffrey Lucey
Publication year - 2003
Publication title -
the canadian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 117
eISSN - 1497-0015
pISSN - 0706-7437
DOI - 10.1177/070674370304800712
Subject(s) - schizophrenia (object oriented programming) , cognition , psychology , psychiatry , cognitive therapy , psychosis , psychotherapist , medicine , clinical psychology
We read with interest Dr Duggal’s letter on the combined use of atypical antipsychotics (AAs) and cognitivebehavioural therapy (CBT) in schizophrenia (1). Dr Duggal reports that his patient showed a reduction of 54% in symptom severity as indexed by the Positive and Negative Syndrome Scale (PANSS). His baseline score when unmedicatedwas 129 and varied from 83 to 102 with medication; when medication was combined with CBT, his PANSS score was 59.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom